Randomized controlled trial shows Nordic walking enhances walking ability in peritoneal dialysis patients, indicating potential benefits for exercise tolerance.
Background Nordic walking (NW) is a four‐point walking style that may improve exercise tolerance in chronic diseases, but its effects in peritoneal dialysis (PD) patients remain unclear. Methods PD patients with sarcopenia and/or musculoskeletal pain were randomly assigned to NW or usual care. The intervention consisted of NW for 20–30 min/day, at least three times per week for 12 weeks. The primary endpoint was the change in 6‐min walking distance (6MWD). Results Twenty‐four patients were enrolled (13 in the intervention group, 11 in the usual care group; age 74.0 ± 6.8 years; 6MWD 391.0 ± 58.1 m). Instructional compliance was 96% in the intervention group. The change in 6MWD was greater in the intervention group than in usual care (33.1 ± 33.5 vs. 4.9 ± 32.9 m), reaching borderline significance ( p = 0.05). Conclusion NW may be associated with improved walking ability in PD patients with sarcopenia or musculoskeletal pain, with a high adherence rate. Trial Registration: UMIN‐CTR no.: UMIN 000052466
No takes yet. Share an insight, caveat, or question.
Sonoda et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: